Search

Your search keyword '"Jacobs BS"' showing total 79 results

Search Constraints

Start Over You searched for: Author "Jacobs BS" Remove constraint Author: "Jacobs BS"
79 results on '"Jacobs BS"'

Search Results

1. Skin cancers arising within tattoos: A systematic reviewCapsule Summary

3. Age, 12-Step Group Involvement, and Relapse Affect Use of Sobriety Date as Recovery Start Date: A Mixed Methods Analysis

4. Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated Rituximab

5. Homocysteine as a Risk Factor for Ischemic Stroke: An Epidemiological Story in Evolution

6. Production of charged pions, kaons and protons at large transverse momenta in pp and Pb–Pb collisions at √sNN = 2.76 TeV

7. Centrality dependence of the pseudorapidity density distribution for charged particles in Pb-Pb collisions at √sNN = 2.76 TeV

11. Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.

15. Accuracy of identifying acute stroke admissions in a Michigan Stroke Registry.

16. Nurse Executives Impacting the Human Experience in Health Care.

17. Changes in cerebral arterial pulsatility and hippocampal volume: a transcranial doppler ultrasonography study.

18. Cultivating a Culture:: Implementing Methods to Embrace Diversity and Inclusion.

20. Parallel functional differentiation of an invasive annual plant on two continents.

21. Differentiation in native as well as introduced ranges: germination reflects mean and variance in cover of surrounding vegetation.

23. Effect of fosamprenavir/ritonavir on the pharmacokinetics of single-dose olanzapine in healthy volunteers.

24. Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: a 'tour de force' for clinical pharmacologists.

26. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.

27. Quantifying how fine-grained environmental heterogeneity and genetic variation affect demography in an annual plant population.

29. G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

30. Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults.

31. Synergistic effects of the MTHFR C677T polymorphism and hypertension on spatial navigation.

32. Brain-derived neurotrophic factor Val66Met and blood glucose: a synergistic effect on memory.

33. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

34. Proteasome inhibitors in the clinical setting: benefits and strategies to overcome multiple myeloma resistance to proteasome inhibitors.

35. Closing gaps between evidence-based stroke care guidelines and practices with a collaborative quality improvement project.

36. Detection of carotid stenosis in African Americans with ischemic heart disease.

37. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.

38. Improved quality of stroke care for hospitalized Medicare beneficiaries in Michigan.

39. Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma.

40. Hospital surveillance of acute stroke treatment in Michigan.

41. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.

42. Can statins treat the strokes they fail to prevent?

43. Acute ischemic stroke in hospitalized medicare patients: evaluation and treatment.

45. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction.

46. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.

47. Stroke in the young in the northern Manhattan stroke study.

48. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.

49. Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.

50. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).

Catalog

Books, media, physical & digital resources